title: Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.
abstract: Cap43 is a nickel- and calcium-inducible gene that plays important roles in the primary growth of malignant tumors, as well as in invasion and metastasis, most likely through its ability to induce cellular differentiation. This study investigated associations of Cap43 expression with angiogenesis and other clinicopathological factors in cervical adenocarcinoma. The clinical records of 100 women who underwent surgery for cervical adenocarcinoma were reviewed retrospectively. Microvessel density and the expression of Cap43 and VEGF in the surgical specimens were evaluated immunohistochemically. The Cap43 expression level was significantly associated with angiogenesis, tumor diameter, stromal invasion, lymphovascular space invasion, lymph node metastasis, and histopathological differentiation. Kaplan-Meier analysis showed a significant association between the Cap43 expression level and survival: high Cap43 expression was related to poor survival. Our results suggest that increased expression of Cap43 is associated with angiogenesis and may be a poor prognostic indicator in women with cervical adenocarcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan. shinshin@med.kurume-u.ac.jp
authors.forename: Shin
authors.initials: S
authors.lastname: Nishio
authors.forename: Kimio
authors.initials: K
authors.lastname: Ushijima
authors.forename: Naotake
authors.initials: N
authors.lastname: Tsuda
authors.forename: Shuji
authors.initials: S
authors.lastname: Takemoto
authors.forename: Kouichiro
authors.initials: K
authors.lastname: Kawano
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: Naoyo
authors.initials: N
authors.lastname: Nishida
authors.forename: Tatsuyuki
authors.initials: T
authors.lastname: Kakuma
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Tsuda
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kasamatsu
authors.forename: Yuko
authors.initials: Y
authors.lastname: Sasajima
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Kage
authors.forename: Michihiko
authors.initials: M
authors.lastname: Kuwano
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Kamura
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology; D000328:Adult; D000368:Aged; D018797:Cell Cycle Proteins / Q000378:metabolism*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008875:Middle Aged; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D015854:Up-Regulation; D002583:Uterine Cervical Neoplasms / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D000099259:N-myc Downstream-Regulated Gene 1 Protein
chemical_list: D018797:Cell Cycle Proteins; D047908:Intracellular Signaling Peptides and Proteins; D042461:Vascular Endothelial Growth Factor A; D000099259:N-myc Downstream-Regulated Gene 1 Protein